SESSION 10: NEW DEVELOPMENTS IN CAROTID DISEASE AND ITS TREATMENT; DIFFERING VIEWS ON TREATMENT OF ASYMPTOMATIC CAROTID STENOSIS (ACS) AND CAROTID SCREENING
Location: Grand Ballroom West, 3rd Floor
Moderators: Ali F. AbuRahma, MD / Bruce A. Perler, MD, MBA / Thomas G. Brott, MD
Moderators: Ali F. AbuRahma, MD / Bruce A. Perler, MD, MBA / Thomas G. Brott, MD
7:50 AM - 7:55 AM
A Data-Driven Look At Interventions For Carotid Disease: Do They Represent Exuberant Enthusiasm, Financial Opportunity For Industry, Doctors And Institutions, Or A Path To Excessive Risk
Presenter(s): Colin P. Derdeyn, MD
Location: Grand Ballroom West, 3rd Floor
7:56 AM - 8:01 AM
Ten-Year Results Of A Multicenter RCT Showing The Long-Term Benefit In CS Patients Of Pre CEA Coronary Angiography And Treatment In Preventing Late MIs And Death
Presenter(s): Jean-Baptiste Ricco, MD, PhD
Location: Grand Ballroom West, 3rd Floor
8:02 AM - 8:07 AM
Asymptomatic Coronary Artery Disease Is Deadly In Patients With Carotid Stenosis (CS) Whether The CS Is Treated Invasively Or Not: An RCT Shows How The Coronary Artery Disease Can Be Quantified And Treated To Reduce Myocardial Infarction And Improve Long-Term Survival
Presenter(s): Dainis K. Krievins, MD / Christopher K. Zarins, MD
Location: Grand Ballroom West, 3rd Floor
8:08 AM - 8:13 AM
Practice Patterns (CAS, CEA, Medical Treatment, TCAR) For Treatment Of CS Are Changing Dramatically From Those In Previous RCTs: Evidence From A Population Based Analysis
Presenter(s): Christian A. Behrendt, MD
Location: Grand Ballroom West, 3rd Floor
8:14 AM - 8:19 AM
Power Point Presentation with Synched Audio
Power Point Presentation with Synched Audio
The Case Against Screening For ACS (Like Lifeline): Who Profits: It May Lead To Unnecessary And Possibly Harmful Invasive Treatments
Presenter(s): Anne L. Abbott, MD, PhD, FRACP
Location: Grand Ballroom West, 3rd Floor
8:20 AM - 8:25 AM
Screening For ACS: Its Main Value Is In Guiding Lipid Treatment: How Low Should LDL-Cholesterol (LDL-C) Be Pushed And What Will It Do To Carotid Plaques
Presenter(s): Stavros K. Kakkos, MD, PhD / Andrew N. Nicolaides, MS, FRCS
Location: Grand Ballroom West, 3rd Floor
8:26 AM - 8:32 AM
Panel Discussion
8:32 AM - 8:37 AM
Plaque Progression In Asymptomatic Carotid Stenosis (ACS) Patients On Best Medical Therapy (BMT): Does It Mandate Invasive Therapy Or Continued BMT
Presenter(s): Gianluca Faggioli, MD
Location: Grand Ballroom West, 3rd Floor
8:38 AM - 8:43 AM
Power Point Presentation with Synched Audio
Power Point Presentation with Synched Audio
DEBATE: All ACS Patients Are Best Treated Medically: Invasive Treatment Causes More Harm Than Good And Should Not Have Been Widely Reimbursed By CMS
Presenter(s): Anne L. Abbott, MD, PhD, FRACP
Location: Grand Ballroom West, 3rd Floor
8:44 AM - 8:49 AM
DEBATE: Not So: About 25% Of ACS Patients Can Benefit From CEA Or CAS And Should Be So Treated And Reimbursed Accordingly
Presenter(s): Bruce A. Perler, MD, MBA
Location: Grand Ballroom West, 3rd Floor
8:50 AM - 8:55 AM
DEBATE: Both Views Are Wrong: Severe ACS Has Declined As A Cause Of Ischemic Stroke To <1% Per Year: So Only <5% Of ACS Patients Should Be Treated Invasively And Reimbursed Accordingly: Can Computer Analysis Of Plaque CT Imaging Help
Presenter(s): Robert W. Chang, MD
Location: Grand Ballroom West, 3rd Floor
8:56 AM - 9:01 AM
CMS Expansion Of Reimbursement For CAS For Asymptomatic Disease: An Expensive And Potentially Harmful Decision: How Could CMS Disregard The Evidence, And Why Couldn't They Wait For CREST 2 Results
Presenter(s): Joseph L. Mills, MD
Location: Grand Ballroom West, 3rd Floor
9:02 AM - 9:07 AM
Is Transfemoral CAS Being Overused One Year After CMS Increased Reimbursement For Treating Asymptomatic Carotid Stenosis
Presenter(s): Sean P. Lyden, MD
Location: Grand Ballroom West, 3rd Floor
9:08 AM - 9:14 AM
Panel Discussion
9:15 AM - 9:30 AM
Break – Visit Exhibits And Pavilions (2nd and 3rd Floors)